Drug profile · INN
diazoxide choline
VIOKAT
diazoxide choline (VIOKAT) is an FDA-listed pharmaceutical active ingredient. Associated with SOLENO THERAPEUTICS INC. Route of administration: oral. Current US regulatory status: approved.
Drug details — diazoxide choline
- US status
- approved
- Class
- Nervous system (N07)
- Route
- ORAL
- Patents
- 6
- Programs
- 1
- Data quality
- 0.89
Quick answer
diazoxide choline (VIOKAT) is an FDA-listed pharmaceutical active ingredient. Associated with SOLENO THERAPEUTICS INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 9757384
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 7799777
Salts of potassium ATP channel openers and uses thereof
granted -
US 7572789
Salts of potassium ATP channel openers and uses thereof
granted
Frequently asked questions
What is diazoxide choline?
diazoxide choline (VIOKAT) is an FDA-listed pharmaceutical active ingredient. Associated with SOLENO THERAPEUTICS INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diazoxide choline?
VIOKAT is a marketed brand name for diazoxide choline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diazoxide choline?
diazoxide choline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.